Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc a clinicalstage biotechnology company engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction Its lead product candidate is ANEB001 a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose The company was incorporated in 2020 and is based in Lakeway Texas